Skip to main content
. 2021 Sep 8;13(18):4516. doi: 10.3390/cancers13184516

Table 2.

Postoperative data.

Title All Patients
(n = 73; 100%)		 UICC
Stage III
(n = 30; 100%)		 UICC
Stage IV
(n = 43; 100%)		 p-Value
Resection status; n (%)
  • –

    R0

 27 (37) 16 (53.3) 11 (25.5) 0.052
  • –

    R1

 31 (42.5) 9 (30) 22 (51.2)
  • –

    R2

 15 (20.5) 5 (16.7) 10 (23.3)
Postoperative complications; n (%) 41 (56.2) 13 (43.3) 28 (65.1)
  • –

    Grade 1

 7 (9.6) 1 (3.3) 6 (14) 0.15
  • –

    Grade 2

 14 (19.2) 7 (23.3) 7 (16.3)
  • –

    Grade 3A

 5 (6.8) 2 (6.6) 3 (7)
  • –

    Grade 3B

 13 (17.8) 2 (6.6) 11 (25.6)
  • –

    Grade 4A

 0 (0) 0 (0) 0 (0)
  • –

    Grade 4B

 0 (0) 0 (0) 0 (0)
  • –

    Grade 5

 2 (2.7) 1 (3.3) 1 (2.3)
Surgical revision; n (%) 13 (17.8) 2 (6.6) 11 (25.6) 0.038
Adjuvant therapy; n (%)
  • –

    Chemotherapy

 26 (35.6) 7 (23.3) 19 (44.2) 0.10
  • –

    Radiotherapy

 24 (32.9) 14 (46.7) 10 (23.3) 0.020
In-hospital mortality; n (%) 2 (2.7) 1 (3.3) 1 (2.3) 0.80